Koniku
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- Undisclosed
Investors
- 4
About Koniku
Koniku Inc.Founded in 2015 in San Rafael, US, Koniku Inc. develops neuron-based technologies for various industries. The company has pivoted its focus to incorporate advanced detection systems, enhancing its offerings across security and agriculture. The founder, Christopher H, has a background that includes previous entrepreneurial ventures.Koniku® specializes in developing innovative co-processors utilizing biological neurons that autonomously learn from sensory inputs. Their core products enhance security measures, including advanced airport security systems to detect threats before checkpoints, drones for locating buried IEDs, and devices for quality assurance in agriculture.Koniku generates revenue primarily through business-to-business transactions with governments, military organizations, and commercial entities in security and agriculture. Their revenue model includes direct sales of proprietary neuron-based technologies and potential licensing agreements.Koniku plans to enhance its product line with new innovative technologies aimed at improving their existing offerings. The company is targeting expansion into additional markets, specifically within Europe and Asia, by 2025.
Who invested in Koniku
4 investors across 3 rounds
See all investors in Koniku
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Koniku
Who invested in Koniku?
Koniku has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Koniku raised?
Koniku has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Koniku last raise money?
Koniku's most recent round on record is a Series A, in Dec 2021.
What does Koniku do?
Koniku is a biotechnology company.
Where is Koniku headquartered?
Koniku is headquartered in San Rafael, US.
Which VCs invest in companies like Koniku?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Koniku's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Koniku? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.